» Articles » PMID: 15681849

HOXA9 Activates Transcription of the Gene Encoding Gp91Phox During Myeloid Differentiation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2005 Feb 1
PMID 15681849
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The CYBB gene encodes gp91Phox; a component of the phagocyte respiratory burst oxidase. CYBB transcription is restricted to myeloid cells differentiated beyond the promyelocyte stage. In undifferentiated myeloid cells, the homeodomain (HD) transcription factor HoxA10 represses CYBB transcription via a cis element in the proximal promoter. During myelopoiesis, phosphorylation of conserved tyrosine residues in the HD decreases HoxA10 binding to this CYBB cis element. In the current studies, we found HoxA9 activates CYBB transcription in differentiated myeloid cells via the same cis element. We find HoxA9-mediated CYBB-transcription requires Pbx1 but is inhibited by Meis1. Additionally, phosphorylation of the conserved HD tyrosines increases HoxA9 binding to the CYBB promoter. The HOXA9 gene is involved in leukemia-associated translocations with the gene encoding Nup98, a nucleopore protein. We find expression of a Nup98-hoxA9 fusion protein blocks HoxA9-induced CYBB transcription in differentiating myeloid cells. In comparison to HoxA9, Nup98-hoxA9 has greater binding affinity for the CYBB cis element, but binding is not altered by HD tyrosine phosphorylation. Therefore, these studies identify CYBB as a common target gene repressed by HoxA10 and activated by HoxA9. These studies also suggest overexpression of Meis1 or Nup98-hoxA9 represses myeloid-specific gene transcription, thereby contributing to differentiation block in leukemogenesis.

Citing Articles

Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis.

Shenoy U, Basavarajappa D, Kabekkodu S, Radhakrishnan R Clin Exp Med. 2024; 24(1):134.

PMID: 38904676 PMC: 11192824. DOI: 10.1007/s10238-024-01389-x.


HOXA9 transcription factor is a double-edged sword: from development to cancer progression.

Shenoy U, Adiga D, Alhedyan F, Kabekkodu S, Radhakrishnan R Cancer Metastasis Rev. 2023; 43(2):709-728.

PMID: 38062297 PMC: 11156722. DOI: 10.1007/s10555-023-10159-2.


Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential.

Tang L, Peng L, Tan C, Liu H, Chen P, Wang H Cancer Cell Int. 2022; 22(1):349.

PMID: 36376832 PMC: 9664671. DOI: 10.1186/s12935-022-02767-9.


Ellagic acid and its fermentative derivative urolithin A show reverse effects on the gp91-phox gene expression, resulting in opposite alterations in all- retinoic acid-induced superoxide generating activity of U937 cells.

Kikuchi H, Harata K, Madhyastha H, Kuribayashi F Biochem Biophys Rep. 2021; 25:100891.

PMID: 33490645 PMC: 7806786. DOI: 10.1016/j.bbrep.2020.100891.


An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in -rearranged acute myeloid leukemia in mice.

Wang H, Shah C, Hu L, Huang W, Platanias L, Eklund E J Biol Chem. 2020; 295(28):9663-9675.

PMID: 32467231 PMC: 7363149. DOI: 10.1074/jbc.RA120.013206.